Decoy Therapeutics (DCOY) Prepaid Assets (2014 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Prepaid Assets of $537044.0 for Q1 2026, up 771.36% year-over-year from $61633.0 in Q1 2025, and up 563.44% quarter-over-quarter from $80949.0 in Q3 2025.
Decoy Therapeutics (DCOY) Prepaid Assets (2014 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Prepaid Assets for 13 consecutive years, with $537044.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 771.36% year-over-year to $537044.0; the TTM figure through Mar 2026 stood at $537044.0 (up 771.36% YoY), while the FY2024 annual figure was $553034.0, down 10.77% from the prior year.
- Prepaid Assets climbed to $537044.0 in Q1 2026 per DCOY's latest filing, from $80949.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.1 million in Q3 2022 and bottomed at $61633.0 in Q1 2025.
- Historically, Prepaid Assets has averaged $452903.4 across 5 years, with a median of $497054.0 in 2024.
- Annual changes were most pronounced in 2025 — Prepaid Assets plunged 86.52% — and 2026, when it jumped 771.36%.
- Decoy Therapeutics' Prepaid Assets stood at $803373.0 in 2022, then retreated by 22.85% to $619763.0 in 2023, then dropped by 10.77% to $553034.0 in 2024, then sank by 85.36% to $80949.0 in 2025, then soared by 563.44% to $537044.0 in 2026.
- Business Quant data shows DCOY's Prepaid Assets at $537044.0 in Q1 2026, $80949.0 in Q3 2025, and $564692.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 284,200.00 |
| Mar 31, 2026 | 537,044.00 |
| Sep 30, 2025 | 80,949.00 |
| Jun 30, 2025 | 564,692.00 |
| Mar 31, 2025 | 61,633.00 |
| Dec 31, 2024 | 553,034.00 |
| Sep 30, 2024 | 119,015.00 |
| Jun 30, 2024 | 241,068.00 |
| Mar 31, 2024 | 457,064.00 |
| Dec 31, 2023 | 619,763.00 |
| Sep 30, 2023 | 743,196.00 |
| Jun 30, 2023 | 284,807.00 |
| Mar 31, 2023 | 156,509.00 |
| Dec 31, 2022 | 803,373.00 |
| Sep 30, 2022 | 1.15 Mn |
| Jun 30, 2022 | 215,642.00 |
| Mar 31, 2022 | 662,854.00 |
| Dec 31, 2021 | 949,215.00 |
| Sep 30, 2021 | 1.19 Mn |
| Jun 30, 2021 | 141,551.00 |